LSD: From 60s Counterculture to Doctor's Office
- Joshua Fisher
In the 1960s, a psychologist and former Harvard teacher named Timothy Leary coined the phrase ‘Turn on. Tune in. Drop out.’ The slogan was inspired by advertising jingles, but Leary wasn’t pushing a product, he was promoting a drug: LSD.
LSD was little more than a scientific curiosity in the early 1960s when Leary first took it. Developed by a Swiss pharmaceutical company, the drug had been sent out into the world in the 1940’s and 50’s with no clear idea of what it might do. At first, researchers used LSD to mimic psychosis in an attempt to study the origins and nature of schizophrenia. It was also given surreptitiously to soldiers in the search for a military application. But the most promising use of LSD was as an aide in psychotherapy, particularly when aimed at problems like alcohol addiction or depression and anxiety in terminal cancer patients.
And then along came Timothy Leary. He had conducted research at Harvard with psilocybin, another psychedelic drug derived from mushrooms. But after trying LSD, he became convinced the drug had even greater potential beyond the scientific realm and began preaching that young people could change their lives with an LSD trip. Before long, as the drug grew more popular, the stories about the dangers of recreational street use grew and it was declared a schedule one drug – the class of highly dangerous drugs with high potential for abuse and no accepted medical use.
But today, scientists are studying psychedelics once again, in the latest twist in the long, strange story of LSD.
More Like This
Myths and Misperceptions about Eating Disorders
30 million people will suffer from eating disorders in their lifetime, yet decades after Karen Carpenter died from anorexia, myths about eating disorders continue.
D&D: Lessons from a Media Panic
Dungeons and Dragons was once accused of leading children to Satanism, but today the game looks more like a solution to a problem plaguing modern parenting.
A Trusted Pill Turned Deadly. How Tylenol Made a Comeback
How do some companies regain public trust after something goes seriously wrong, while others fail? A look at how Tylenol responded after someone spiked its pills with poison in the 1980s sheds some light.
Finding the Code: The Race to Sequence the Human Genome and What It Means
One of biology’s most spectacular achievements -- the race to sequence the human genome -- was billed as a way to end disease. Here's where it led.